- Home
- BWEN vs ANTX Comparison
BWEN vs ANTX Comparison
Compare BWEN & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BWEN
- ANTX
- Stock Information
- Founded
- BWEN N/A
- ANTX 2017
- Country
- BWEN United States
- ANTX United States
- Employees
- BWEN N/A
- ANTX N/A
- Industry
- BWEN Industrial Machinery/Components
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- BWEN Industrials
- ANTX Health Care
- Exchange
- BWEN Nasdaq
- ANTX Nasdaq
- Market Cap
- BWEN 39.1M
- ANTX 40.0M
- IPO Year
- BWEN N/A
- ANTX 2022
- Fundamental
- Price
- BWEN $1.85
- ANTX $1.27
- Analyst Decision
- BWEN Strong Buy
- ANTX Hold
- Analyst Count
- BWEN 3
- ANTX 5
- Target Price
- BWEN $5.17
- ANTX $3.50
- AVG Volume (30 Days)
- BWEN 153.1K
- ANTX 387.1K
- Earning Date
- BWEN 11-13-2024
- ANTX 11-13-2024
- Dividend Yield
- BWEN N/A
- ANTX N/A
- EPS Growth
- BWEN N/A
- ANTX N/A
- EPS
- BWEN 0.14
- ANTX N/A
- Revenue
- BWEN $156,169,000.00
- ANTX N/A
- Revenue This Year
- BWEN N/A
- ANTX N/A
- Revenue Next Year
- BWEN $25.42
- ANTX N/A
- P/E Ratio
- BWEN $13.21
- ANTX N/A
- Revenue Growth
- BWEN N/A
- ANTX N/A
- 52 Week Low
- BWEN $1.52
- ANTX $0.87
- 52 Week High
- BWEN $4.65
- ANTX $22.22
- Technical
- Relative Strength Index (RSI)
- BWEN 53.51
- ANTX 43.86
- Support Level
- BWEN $1.74
- ANTX $1.23
- Resistance Level
- BWEN $1.87
- ANTX $1.59
- Average True Range (ATR)
- BWEN 0.10
- ANTX 0.08
- MACD
- BWEN 0.01
- ANTX -0.04
- Stochastic Oscillator
- BWEN 37.93
- ANTX 8.11
About BWEN Broadwind Inc.
Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through three operating segments namely Heavy Fabrications, Gearing and Industrial Solutions.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.